Aeterna Wealth
Index Fund · Regular plan · Growth

Tata Nifty MidSmall Healthcare Index Fund (Regular)

Tata Mutual Fund · benchmark Nifty Midsmall Healthcare TRI · 2.5 years old · AMFI code 152567

A
Track-record rating: 1 of 2 in Index: NIFTY MIDSMALL HEALTHCARE

A (top 30%), score 57.4 out of 100. Describes the past, not a forecast.

Returns against the index

PeriodFundIndex (TRI)DifferenceRank in category
6 months14.5%15.2%-0.7%1 / 2
1 year18.0%19.4%-1.4%1 / 2
3 years (a year)––––
5 years (a year)––––

Growth option, point to point to 5 Nov 2026; periods over a year are annualised (CAGR). Index returns use the total-return index, which includes dividends.

Risk

Tracking difference, 1Y-1.36%
Tracking error, 1Y0.07%

Portfolio

LAURUS LABS LTD11.8%
LUPIN LTD7.6%
AUROBINDO PHARMA LTD7.1%
FORTIS HEALTHCARE LTD6.2%
GLENMARK PHARMACEUTICALS LTD5.4%
ALKEM LABORATORIES LTD4.8%
MANKIND PHARMA LTD4.4%
IPCA LABORATORIES LTD4.1%
BIOCON LTD4.0%
GLAND PHARMA LTD3.5%

Top 10 holdings, September 2026 portfolio.

Common questions

What is the NAV of Tata Nifty MidSmall Healthcare Index Fund (Regular plan)?

₹15.29 on 5 Nov 2026 (Growth option).

What is the expense ratio of Tata Nifty MidSmall Healthcare Index Fund (Regular)?

1.15% a year; the Direct plan's is 0.59%.

What does Tata Nifty MidSmall Healthcare Index Fund invest in?

Its largest holdings are LAURUS LABS LTD, LUPIN LTD, AUROBINDO PHARMA LTD, with 21 stocks in all (September 2026 portfolio).

How is Tata Nifty MidSmall Healthcare Index Fund rated?

A: 1 of 2 Regular plans in Index: NIFTY MIDSMALL HEALTHCARE, on its track record. This describes the past and is not a recommendation.

Data as of 5 Nov 2026: NAVs from AMFI, index data from NSE Indices, portfolios from Tata Mutual Fund's monthly disclosure. Updated every weekday. Read the scheme documents before investing.